NEW YORK (360Dx) – Quest Diagnostics and Oxford Immunotec Global announced this week that Quest has completed its previously announced acquisition of Oxford Immunotec's US laboratory services business. The T-Spot.TB tuberculosis and the Accutix tick-borne disease testing services are now part of Quest's portfolio.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.